WallStreetZenWallStreetZen

NASDAQ: SWTX
Springworks Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SWTX

Based on 2 analysts offering 12 month price targets for Springworks Therapeutics Inc.
Min Forecast
$68.00+75.48%
Avg Forecast
$72.00+85.81%
Max Forecast
$76.00+96.13%

Should I buy or sell SWTX stock?

Based on 2 analysts offering ratings for Springworks Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SWTX stock forecasts and price targets.

SWTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-04Find Out Why
lockedlocked$00.00+00.00%2024-08-28

1 of 1

Forecast return on equity

Is SWTX forecast to generate an efficient return?
Company
29.88%
Industry
-388.81%
Market
59.09%
SWTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SWTX forecast to generate an efficient return on assets?
Company
26.95%
Industry
27.33%
SWTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SWTX earnings per share forecast

What is SWTX's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$3.36
Avg 2 year Forecast
-$1.87
Avg 3 year Forecast
-$0.26

SWTX revenue forecast

What is SWTX's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$199.3M+131.22%
Avg 2 year Forecast
$396.6M+360.2%
Avg 3 year Forecast
$618.9M+618.14%
SWTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SWTX revenue growth forecast

How is SWTX forecast to perform vs Biotechnology companies and vs the US market?
Company
92.41%
Industry
34.98%
Market
9.26%
SWTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SWTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SWTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SWTX$38.75$72.00+85.81%Strong Buy
CLDX$43.76$61.33+40.16%Buy
XENE$38.47$57.80+50.25%Strong Buy
MLTX$46.02$82.00+78.18%Buy
KYMR$45.40$47.00+3.52%Buy
View Top Biotech Stocks

Springworks Therapeutics Stock Forecast FAQ

Is Springworks Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SWTX) stock is to Strong Buy SWTX stock.

Out of 2 analysts, 1 (50%) are recommending SWTX as a Strong Buy, 1 (50%) are recommending SWTX as a Buy, 0 (0%) are recommending SWTX as a Hold, 0 (0%) are recommending SWTX as a Sell, and 0 (0%) are recommending SWTX as a Strong Sell.

If you're new to stock investing, here's how to buy Springworks Therapeutics stock.

What is SWTX's earnings growth forecast for 2024-2026?

(NASDAQ: SWTX) Springworks Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Springworks Therapeutics's earnings in 2024 is -$301,063,000.On average, 6 Wall Street analysts forecast SWTX's earnings for 2024 to be -$249,186,006, with the lowest SWTX earnings forecast at -$320,859,477, and the highest SWTX earnings forecast at -$210,192,666. On average, 6 Wall Street analysts forecast SWTX's earnings for 2025 to be -$139,135,661, with the lowest SWTX earnings forecast at -$247,329,180, and the highest SWTX earnings forecast at $8,170,033.

In 2026, SWTX is forecast to generate -$19,125,304 in earnings, with the lowest earnings forecast at -$173,798,883 and the highest earnings forecast at $52,733,849.

What is SWTX's revenue growth forecast for 2024-2026?

(NASDAQ: SWTX) Springworks Therapeutics's forecast annual revenue growth rate of 92.41% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.26%.

Springworks Therapeutics's revenue in 2024 is $86,186,000.On average, 5 Wall Street analysts forecast SWTX's revenue for 2024 to be $14,800,980,275, with the lowest SWTX revenue forecast at $13,359,489,366, and the highest SWTX revenue forecast at $15,644,870,407. On average, 5 Wall Street analysts forecast SWTX's revenue for 2025 to be $29,458,465,061, with the lowest SWTX revenue forecast at $23,134,562,450, and the highest SWTX revenue forecast at $33,781,600,870.

In 2026, SWTX is forecast to generate $45,970,175,966 in revenue, with the lowest revenue forecast at $35,509,191,478 and the highest revenue forecast at $56,054,596,207.

What is SWTX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SWTX) forecast ROA is 26.95%, which is lower than the forecast US Biotechnology industry average of 27.33%.

What is SWTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SWTX price target, the average SWTX price target is $72.00, with the highest SWTX stock price forecast at $76.00 and the lowest SWTX stock price forecast at $68.00.

On average, Wall Street analysts predict that Springworks Therapeutics's share price could reach $72.00 by Sep 4, 2025. The average Springworks Therapeutics stock price prediction forecasts a potential upside of 85.81% from the current SWTX share price of $38.75.

What is SWTX's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: SWTX) Springworks Therapeutics's current Earnings Per Share (EPS) is -$4.44. On average, analysts forecast that SWTX's EPS will be -$3.36 for 2024, with the lowest EPS forecast at -$4.32, and the highest EPS forecast at -$2.83. On average, analysts forecast that SWTX's EPS will be -$1.87 for 2025, with the lowest EPS forecast at -$3.33, and the highest EPS forecast at $0.11. In 2026, SWTX's EPS is forecast to hit -$0.26 (min: -$2.34, max: $0.71).

What is SWTX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SWTX) forecast ROE is 29.88%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.